Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001562180-16-002830
Filing Date
2016-07-21
Accepted
2016-07-21 17:09:14
Documents
1
Period of Report
2016-07-19

Document Format Files

Seq Description Document Type Size
1 PRIMARY DOCUMENT primarydocument.html 4  
1 PRIMARY DOCUMENT primarydocument.xml 4 5667
  Complete submission text file 0001562180-16-002830.txt   6971
Mailing Address 60 LEVERONI COURT NOVATO CA 94949
Business Address 60 LEVERONI COURT NOVATO CA 94949 415-483-8800
Ultragenyx Pharmaceutical Inc. (Issuer) CIK: 0001515673 (see all company filings)

EIN.: 272546083 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations

Mailing Address 60 LEVERONI COURT NOVATO CA 94949
Business Address
AGARWAL SUNIL (Reporting) CIK: 0001616640 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-36276 | Film No.: 161777858